NanoSynex Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Grant
  • (Announced)

  • Latest Deal Amount
  • $3.02M

  • Investors
  • 1

NanoSynex General Information

Description

Developer of antimicrobial susceptibility tests designed to check bacterial resistance to antibiotics. The company's tests are based on a phenotypic approach and use a microfluidic disposable test card platform and method that optimizes bacterial growth, enabling doctors to determine the appropriate antibiotic treatment for their patients and offer same-day results.

Contact Information

Website
www.nanosynex.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Pinhas Sapir 7
  • Ness Ziona 6334600
  • Israel
Primary Industry
Diagnostic Equipment
Parent Company
Qualigen Therapeutics
Vertical(s)
Life Sciences
Corporate Office
  • Pinhas Sapir 7
  • Ness Ziona 6334600
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoSynex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
21. Grant 01-Oct-2020 $3.02M Announced Product Development
20. Grant 16-Oct-2023 Completed Product Development
19. Later Stage VC 08-Feb-2023 Completed Product Development
18. Merger/Acquisition 02-Jun-2022 Completed Product Development
17. Grant 25-Nov-2021 Completed Product Development
16. Early Stage VC 12-May-2021 Completed Product Development
15. Grant 12-Jan-2021 Completed Product Development
14. Grant 19-Nov-2020 Completed Product Development
13. Early Stage VC 07-May-2020 $113K $1.48M Completed Product Development
12. Early Stage VC 22-Nov-2019 $171K $1.37M Completed Product Development
To view NanoSynex’s complete valuation and funding history, request access »

NanoSynex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antimicrobial susceptibility tests designed to check bacterial resistance to antibiotics. The company's tes
Diagnostic Equipment
Ness Ziona, Israel
13 As of 2023

Polverara, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NanoSynex Competitors (1)

One of NanoSynex’s competitors is Alifax, a Accelerator/Incubator Backed company based in Polverara, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alifax Accelerator/Incubator Backed Polverara, Italy
You’re viewing 1 of 1 competitors. Get the full list »

NanoSynex Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

NanoSynex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230256447-A1 A microfluidic testing apparatus Pending 16-Jul-2020
EP-4182701-A1 A microfluidic testing apparatus Pending 16-Jul-2020
EP-4182701-A4 A microfluidic testing apparatus Pending 16-Jul-2020
EP-3990187-A4 Method for loading a multiplexed array of nanoliter droplet array devices Pending 30-Jun-2019
EP-3990187-A1 Method for loading a multiplexed array of nanoliter droplet array devices Pending 30-Jun-2019 B01L3/502753
To view NanoSynex’s complete patent history, request access »

NanoSynex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NanoSynex Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
China(Shenzhen)Innovation & Entrepreneurship International Competition Corporation
European Commission Government
European Innovation Council Fund Venture Capital Minority
European Union Government
IBM Alpha Zone accelerator Accelerator/Incubator
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

NanoSynex FAQs

  • When was NanoSynex founded?

    NanoSynex was founded in 2017.

  • Where is NanoSynex headquartered?

    NanoSynex is headquartered in Ness Ziona, Israel.

  • What is the size of NanoSynex?

    NanoSynex has 13 total employees.

  • What industry is NanoSynex in?

    NanoSynex’s primary industry is Diagnostic Equipment.

  • Is NanoSynex a private or public company?

    NanoSynex is a Private company.

  • What is NanoSynex’s current revenue?

    The current revenue for NanoSynex is .

  • How much funding has NanoSynex raised over time?

    NanoSynex has raised $146K.

  • Who are NanoSynex’s investors?

    China(Shenzhen)Innovation & Entrepreneurship International Competition, European Commission, European Innovation Council Fund, European Union, and IBM Alpha Zone accelerator are 5 of 12 investors who have invested in NanoSynex.

  • Who are NanoSynex’s competitors?

    Alifax is a competitor of NanoSynex.

  • When was NanoSynex acquired?

    NanoSynex was acquired on 01-Oct-2020.

  • Who acquired NanoSynex?

    NanoSynex was acquired by Qualigen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »